Yifan Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	13,829	13,040	18,014	15,019	21,745	23,372
Market Cap Growth	9.74%	-27.61%	19.94%	-30.93%	-6.96%	36.83%
Enterprise Value	15,348	14,371	19,400	16,499	22,717	23,710
Last Close Price	13.34	10.63	14.52	12.03	17.31	18.55
PE Ratio	39.27	33.78	-	78.54	78.11	24.14
Forward PE	26.16	20.82	33.59	16.33	32.78	16.68
PS Ratio	2.65	2.53	4.43	3.92	4.93	4.33
PB Ratio	1.59	1.55	2.18	1.64	2.48	2.68
P/TBV Ratio	3.16	3.29	4.67	2.82	4.23	4.70
P/FCF Ratio	-	1037.05	-	-	-	59.50
P/OCF Ratio	22.54	20.35	51.68	31.82	72.19	21.09
PEG Ratio	-	0.21	0.21	0.21	0.21	0.21
EV/Sales Ratio	2.94	2.79	4.77	4.30	5.15	4.39
EV/EBITDA Ratio	19.74	22.36	76.48	43.52	50.06	19.91
EV/EBIT Ratio	38.55	44.07	17820.38	96.29	86.48	23.38
EV/FCF Ratio	-245.64	1142.95	-	-	-	60.36
Debt / Equity Ratio	0.29	0.27	0.24	0.24	0.26	0.19
Debt / EBITDA Ratio	3.24	3.49	7.34	5.44	4.84	1.39
Debt / FCF Ratio	-	182.47	-	-	-	4.23
Net Debt / Equity Ratio	0.19	0.17	0.15	0.10	0.11	0.03
Net Debt / EBITDA Ratio	2.15	2.19	4.82	2.47	2.07	0.24
Net Debt / FCF Ratio	-26.27	111.73	-7.86	-13.35	-3.47	0.74
Asset Turnover	0.41	0.43	0.34	0.31	0.37	0.48
Inventory Turnover	2.36	2.83	2.45	2.65	4.16	4.91
Quick Ratio	0.80	0.84	0.94	1.19	1.13	1.22
Current Ratio	1.27	1.26	1.49	1.68	1.56	1.65
Return on Equity (ROE)	4.39%	3.88%	-10.18%	1.42%	2.77%	11.25%
Return on Assets (ROA)	1.95%	1.71%	0.01%	0.87%	1.38%	5.58%
Return on Invested Capital (ROIC)	3.33%	2.81%	0.01%	1.40%	2.80%	10.17%
Return on Capital Employed (ROCE)	4.10%	3.50%	0.00%	1.70%	2.70%	10.70%
Earnings Yield	2.95%	2.96%	-3.06%	1.27%	1.28%	4.14%
FCF Yield	-0.45%	0.10%	-0.86%	-0.47%	-1.24%	1.68%
Dividend Yield	0.76%	1.88%	-	-	-	0.27%
Payout Ratio	42.85%	50.47%	-	45.18%	49.71%	20.86%
Buyback Yield / Dilution	1.94%	1.51%	3.94%	-5.32%	1.26%	-0.40%
Total Shareholder Return	2.70%	3.39%	3.94%	-5.32%	1.26%	-0.13%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.